Evercore ISI Issues Positive Forecast for Danaher (NYSE:DHR) Stock Price

Key Points

• Evercore ISI has raised its target price for Danaher (NYSE:DHR) from $226.00 to $245.00, reflecting a potential upside of 16.82% based on the company's previous close.
• The average price target among analysts for Danaher is $246.74, with seventeen investment analysts rating the stock as a Buy and four as Hold.
• Danaher reported a 3.4% year-over-year revenue increase, reaching $5.94 billion with an EPS of $1.80, exceeding analysts' expectations.

Danaher (NYSE:DHR - Get Free Report) had its target price raised by Evercore ISI from $226.00 to $245.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an "outperform" rating on the conglomerate's stock. Evercore ISI's price objective indicates a potential upside of 16.82% from the company's previous close.

A number of other analysts have also weighed in on the company. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Danaher in a research note on Saturday, September 27th. Bank of America reduced their target price on shares of Danaher from $230.00 to $220.00 and set a "buy" rating on the stock in a research report on Monday, September 22nd. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Finally, UBS Group dropped their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $246.74.

Danaher Price Performance

Danaher stock traded down $1.99 during trading hours on Tuesday, hitting $209.73. 2,045,892 shares of the stock were exchanged, compared to its average volume of 4,233,085. The stock has a market capitalization of $150.17 billion, a P/E ratio of 44.67, a P/E/G ratio of 3.06 and a beta of 0.77. The business's 50-day moving average is $200.36 and its two-hundred day moving average is $197.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher has a 12 month low of $171.00 and a 12 month high of $279.41.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the company earned $1.72 EPS. Danaher's revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts expect that Danaher will post 7.63 EPS for the current fiscal year.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company's stock.

Hedge Funds Weigh In On Danaher

Several hedge funds have recently added to or reduced their stakes in DHR. Norges Bank bought a new position in Danaher during the 2nd quarter worth approximately $1,979,503,000. Nuveen LLC acquired a new stake in Danaher in the first quarter worth $833,941,000. Viking Global Investors LP boosted its position in shares of Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate's stock worth $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. Generation Investment Management LLP boosted its position in shares of Danaher by 56.2% during the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate's stock worth $980,914,000 after purchasing an additional 1,787,522 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock valued at $965,259,000 after buying an additional 1,450,703 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.